Can Iron Chelators Influence the Progression of Atherosclerosis?

REFERENCES

• Marx JJM. Iron deficiency in developed countries: prevalence, influence of lifestyle factors and hazards of prevention. Eur J Clin Nutr 1997; 51(8)491–494
   PubMed Web of Science ®Google Scholar
• Marx JJM. Pathophysiology and treatment of iron overload in thalassemia patients in tropical countries. Adv Exp Med Biol 2003; 531: 57–68
   PubMed Web of Science ®Google Scholar
• Hider RC. Nature of nontransferrin-bound iron. Eur J Clin Invest 2002; 32(Suppl 1)50–54
   PubMed Web of Science ®Google Scholar
• Loreal O, Gosriwatana I, Guyader D, Porter J, Brissot P, Hider RC. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol 2000; 32(5)727–733
   PubMed Web of Science ®Google Scholar
• Hershko C, Graham G, Bates GW, Rachmilewitz EA. Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol 1978; 40(?)255–263
   PubMed Web of Science ®Google Scholar
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352(16)1685–1695
   PubMed Web of Science ®Google Scholar
• Alpert PT. New and emerging theories of cardiovascular disease: infection and elevated iron. Biol Res Nurs 2004; 6(1)3–10
   PubMedGoogle Scholar
• Qayyum R, Schulman P. Iron and atherosclerosis. Clin Cardiol 2005; 28(3)119–122
   PubMed Web of Science ®Google Scholar
• Lusis AJ, Fogelman AM, Fonarow GC. Genetic basis of atherosclerosis. Part I: new genes and pathways. Circulation 2004; 110(13)1868–1873
   PubMed Web of Science ®Google Scholar
• Lusis AJ, Fogelman AM, Fonarow GC. Genetic basis of atherosclerosis. Part II: clinical implications. Circulation 2004; 110(14)2066–2071
   PubMed Web of Science ®Google Scholar
• Lusis AJ, Mar R, Pajukanta P. Genetics of atherosclerosis. Annu Rev Genomics Hum Genet 2004; 5: 189–218
   PubMed Web of Science ®Google Scholar
• Ghazalpour A, Doss S, Yang X, Aten J, Toomey EM, Van NA, Wang S, Drake TA, Lusis AJ. Thematic review series: The pathogenesis of atherosclerosis. Toward a biological network for atherosclerosis. J Lipid Res 2004; 45(10)1793–1805
   PubMed Web of Science ®Google Scholar
• Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981; 1(8233)1293–1294
   PubMed Web of Science ®Google Scholar
• de Valk B, Marx JJM. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med 1999; 159(14)1542–1548
   PubMedGoogle Scholar
• Ascherio A, Willett WC, Rimm EB, Giovannucci EL, Stampfer MJ. Dietary iron intake and risk of coronary disease among men. Circulation 1994; 89(3)969–974
   PubMed Web of Science ®Google Scholar
• Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and risk of coronary heart disease in men. Circulation 2001; 103(1)52–57
   PubMed Web of Science ®Google Scholar
• Klipstein-Grobusch K, Grobbee DE, den Breeijen JH, Boeing H, Hofman A, Witteman JC. Dietary iron and risk of myocardial infarction in the Rotterdam study. Am J Epidemiol 1999; 149(5)421–428
   PubMed Web of Science ®Google Scholar
• Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86(3)803–811
   PubMed Web of Science ®Google Scholar
• Tuomainen TP, Kontula K, Nyyssonen K, Lakka TA, Helio T, Salonen JT. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation 1999; 100(12)1274–1279
   PubMed Web of Science ®Google Scholar
• van der A DL, Grobbee DE, Roest M, Marx JJM, Voorbij HA, van der Schouw YT. Serum ferritin is a risk factor for stroke in postmenopausal women. Stroke 2005; 36(8)1637–1641
   PubMed Web of Science ®Google Scholar
• van der A DL, Peeters PH, Grobbee DE, Marx JJM, van der Schouw YT. Dietary haem iron and coronary heart disease in women. Eur Heart J 2005; 26(3)257–262
   PubMed Web of Science ®Google Scholar
• van der A DL, Peeters PH, Grobbee DE, Roest M, Marx JJM, Voorbij HM, van der Schouw YT. HFE mutations and risk of coronary heart disease in middle-aged women. Eur J Clin Invest 2006; 36(10)682–690
   PubMed Web of Science ®Google Scholar
• Roest M, van der Schouw YT, de Valk B, Marx JJM, Tempelman MJ, de Groot PG, Sixma JJ, Banga JD. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women [see comments]. Circulation 1999; 100(12)1268–1273
   PubMed Web of Science ®Google Scholar
• van der A DL, Marx JJM, Grobbee DE, Kamphuis MH, Georgiou NA, Kats-Renaud JH, Breuer W, Cabantchik ZI, Roest M, Voorbij HA, van der Schouw YT. Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal women. Circulation 2006; 113(16)1942–1949
   PubMed Web of Science ®Google Scholar
• Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E. Prevalence of coronary heart disease associated with HFE mutations in adults attending a health appraisal center. Am J Med 2002; 113(6)472–479
   PubMed Web of Science ®Google Scholar
• Moura E, Noordermeer MA, Verhoeven N, Verheul AF, Marx JJM. Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients. Blood 1998; 92(7)2511–2519
   PubMed Web of Science ®Google Scholar
• Morales NP, Charlermchoung C, Luechapudiporn R, Yamanont P, Fucharoen S, Chantharaksri U. Lipid fluidity at different regions in LDL and HDL of β-thalassemia/Hb E patients. Biochem Biophys Res Commun 2006; 350(3)698–703
   PubMed Web of Science ®Google Scholar
• Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest 1984; 74(5)1890–1894
   PubMed Web of Science ®Google Scholar
• Smith C, Mitchinson MJ, Aruoma OI, Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J 1992; 286(Pt 3)901–905
   PubMed Web of Science ®Google Scholar
• Pang JH, Jiang MJ, Chen YL, Wang FW, Wang DL, Chu SH, Chau LY. Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest 1996; 97(10)2204–2212
   PubMed Web of Science ®Google Scholar
• Lee FY, Lee TS, Pan CC, Huang AL, Chau LY. Colocalization of iron and ceroid in human atherosclerotic lesions. Atherosclerosis 1998; 138(2)281–288
   PubMed Web of Science ®Google Scholar
• Araujo JA, Romano EL, Brito BE, Parthe V, Romano M, Bracho M, Montano RF, Cardier J. Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vasc Biol 1995; 15(8)1172–1180
   PubMed Web of Science ®Google Scholar
• Lee TS, Shiao MS, Pan CC, Chau LY. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation 1999; 99(9)1222–1229
   PubMed Web of Science ®Google Scholar
• Minqin R, Watt F, Huat BT, Halliwell B. Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions. Free Radic Biol Med 2003; 34(6)746–752
   PubMed Web of Science ®Google Scholar
• Rooyakkers TM, Stroes ES, Kooistra MP, van Faassen EE, Hider RC, Rabelink TJ, Marx JJM. Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur J Clin Invest 2002; 32(Suppl 1)9–16
   PubMed Web of Science ®Google Scholar
• Baldwin AS, Jr. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 2001; 107(1)3–6
   PubMed Web of Science ®Google Scholar
• Li L, Frei B. Iron chelation inhibits NF-κB-mediated adhesion molecule expression by inhibiting p22(phox) protein expression and NADPH oxidase activity. Arterioscler Thromb Vasc Biol 2006; 26(12)2638–2643
   PubMed Web of Science ®Google Scholar
• Visseren FL, Verkerk MS, van der Bruggen T, Marx JJM, van Asbeck BS, Diepersloot RJ. Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A. Eur J Clin Invest 2002; 32(Suppl 1)84–90
   PubMed Web of Science ®Google Scholar
• Zhang WJ, Frei B. Intracellular metal ion chelators inhibit TNFα-induced SP-1 activation and adhesion molecule expression in human aortic endothelial cells. Free Radic Biol Med 2003; 34(6)674–682
   PubMed Web of Science ®Google Scholar
• Koo SW, Casper KA, Otto KB, Gira AK, Swerlick RA. Iron chelators inhibit VCAM-1 expression in human dermal microvascular endothelial cells. J Invest Dermatol 2003; 120(5)871–879
   PubMed Web of Science ®Google Scholar
• Cheung YF, Chan GC, Ha SY. Arterial stiffness and endothelial function in patients with β-thalassemia major. Circulation 2002; 106(20)2561–2566
   PubMed Web of Science ®Google Scholar
• Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney JF, Jr., Vita JA. Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 2001; 103(23)2799–2804
   PubMed Web of Science ®Google Scholar
• Failla M, Giannattasio C, Piperno A, Vergani A, Grappiolo A, Gentile G, Meles E, Mancia G. Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy. Hepatology 2000; 32(3)569–573
   PubMed Web of Science ®Google Scholar
• Lee TS, Lee FY, Pang JH, Chau LY. Erythrophagocytosis and iron deposition in atherosclerotic lesions. Chin J Physiol 1999; 42(1)17–23
   PubMed Web of Science ®Google Scholar
• Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003; 349(24)2316–2325
   PubMed Web of Science ®Google Scholar
• Kartikasari AE, Georgiou NA, Visseren FL, Kats-Renaud H, van Asbeck BS, Marx JJM. Intracellular labile iron modulates adhesion of human monocytes to human endothelial cells. Arterioscler Thromb Vasc Biol 2004; 24(12)2257–2262
   PubMed Web of Science ®Google Scholar
• Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52(11)2745–2756
   PubMed Web of Science ®Google Scholar
• Wahl LM, Katona IM, Wilder RL, Winter CC, Haraoui B, Scher I, Wahl SM. Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysis. Cell Immunol 1984; 85(2)373–383
   PubMed Web of Science ®Google Scholar
• Kartikasari AE, Georgiou NA, Visseren FL, Kats-Renaud H, Sweder vA, Marx JJM. Endothelial activation and induction of monocyte adhesion by nontransferrin-bound iron present in human sera. FASEB J 2006; 20(2)353–355
   PubMed Web of Science ®Google Scholar
• de Valk B, Addicks MA, Gosriwatana I, Lu S, Hider RC, Marx JJM. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 2000; 30(3)248–251
   PubMed Web of Science ®Google Scholar
• Pootrakul P, Breuer W, Sametband M, Sirankapracha P, Hershko C, Cabantchik ZI. Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded β-thalassemia/HbE patients treated with an oral chelator. Blood 2004; 104(5)1504–1510
   PubMed Web of Science ®Google Scholar
• Breuer W, Cabantchik ZI. A fluorescence-based one-step assay for serum non-transferrin-bound iron. Anal Biochem 2001; 299(2)194–202
   PubMed Web of Science ®Google Scholar
• Hershko C, Cook JD, Finch CA. Storage iron kinetics. II. The uptake of hemoglobin iron by hepatic parenchymal cells. J Lab Clin Med 1972; 80(5)624–634
   PubMed Web of Science ®Google Scholar
• Hershko C. The fate of circulating haemoglobin. Br J Haematol 1975; 29(2)199–204
   PubMed Web of Science ®Google Scholar
• Vercellotti GM, Balla G, Balla J, Nath K, Eaton JW, Jacob HS. Heme and the vasculature: an oxidative hazard that induces antioxidant defenses in the endothelium. Artif Cells Blood Substit Immobil Biotechnol 1994; 22(2)207–213
   PubMed Web of Science ®Google Scholar
• Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Eaton JW, Balla G. Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol Nutr Food Res 2005; 49(11)1030–1043
   PubMed Web of Science ®Google Scholar
• Balla J, Vercellotti GM, Nath K, Yachie A, Nagy E, Eaton JW, Balla G. Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant 2003; 18(Suppl 5)v8–12
   PubMed Web of Science ®Google Scholar
• Morita T. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 2005; 25(9)1786–1795
   PubMed Web of Science ®Google Scholar
• Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, Dhingra U, Kabole I, Deb S, Othman MK, Kabole FM. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006; 367(9505)133–143
   PubMed Web of Science ®Google Scholar
• Gordeuk VR, Thuma PE, Brittenham GM, Biemba G, Zulu S, Simwanza G, Kalense P, M'Hango A, Parry D, Poltera AA. Iron chelation as a chemotherapeutic strategy for falciparum malaria. Am J Trop Med Hyg 1993; 48(2)193–197
   PubMed Web of Science ®Google Scholar
• Gordeuk V, Thuma P, Brittenham G, McLaren C, Parry D, Backenstose A, Biemba G, Msiska R, Holmes L, McKinley E. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med 1992; 327(21)1473–1477
   PubMed Web of Science ®Google Scholar
• Hershko C, Gordeuk VR, Thuma PE, Theanacho EN, Spira DT, Hider RC, Peto TE, Brittenham GM. The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria. J Inorg Biochem 1992; 47(3–4)267–277
   PubMed Web of Science ®Google Scholar
• Cabantchik ZI, Glickstein H, Golenser J, Loyevsky M, Tsafack A. Iron chelators: mode of action as antimalarials. Acta Haematol 1996; 95(1)70–77
   PubMed Web of Science ®Google Scholar